[Treatment of conjunctival intraepithelial neoplasia with topical mitomycin C 0.02%].
| Autor: | Ramos-López JF; Hospital Universitario La Fe y Fundación Oftalmológica del Mediterráneo (FOM), Valencia, España. juanframos@oftalmogranada.com, Martínez-Costa Pérez R, Cisneros Lanuza AL, Francés Muñoz E, Monte Boque E, Muñoz Gómez MC, López-Sánchez EV, Menezo Rozalén JL |
|---|---|
| Jazyk: | Spanish; Castilian |
| Zdroj: | Archivos de la Sociedad Espanola de Oftalmologia [Arch Soc Esp Oftalmol] 2004 Aug; Vol. 79 (8), pp. 375-8. |
| DOI: | 10.4321/s0365-66912004000800004 |
| Abstrakt: | Purpose: To evaluate the efficacy of topical mitomycin C (MMC) 0.02% in treating conjunctival intraepithelial neoplasia (CIN). Methods: Three patients with CIN were treated with topical MMC 0.02%. Our follow-up period was twelve months (range 8-18 months). Results: CIN was resolved in all three cases without modifying the normal corneal and conjunctival architecture. Conclusions: Topical MMC 0.02% four times daily during two weeks is a useful alternative tool for the surgical management of CIN. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|